| Jul 31 |
Sanofi unit Genzyme sues Sarepta alleging patent infringement in Duchenne drug
|
| Jul 30 |
Novavax Sinks 26%. Vaccine Demand Triggers Downgrade.
|
| Jul 26 |
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
|
| Jul 26 |
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
|
| Jul 25 |
Sanofi ending development of mid-stage dwarfism therapy
|
| Jul 25 |
Sanofi (SNY) Q2 2024 Earnings Call Transcript
|
| Jul 25 |
Ontario Ministry of Health Announces a Universal Public Program with Beyfortus® this RSV Season
|
| Jul 25 |
AstraZeneca Makes A Bearish Move Despite Quarterly Beat As FDA Panel Mulls Cancer Drug
|
| Jul 25 |
Press Release: Online availability of Sanofi’s half-year financial report for 2024
|
| Jul 25 |
Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
|
